92 related articles for article (PubMed ID: 32480248)
1. Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
Bobkova I; Kamyshova E; Rudenko T; Stavrovskaya E; Moiseev S
Med Hypotheses; 2020 Oct; 143():109888. PubMed ID: 32480248
[No Abstract] [Full Text] [Related]
2. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
Bloch MJ
J Am Coll Cardiol; 2020 Jul; 76(3):277-279. PubMed ID: 32674791
[TBL] [Abstract][Full Text] [Related]
3. What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?
Elijovich F; Laffer CL
Hypertension; 2020 Sep; 76(3):665-669. PubMed ID: 32783759
[No Abstract] [Full Text] [Related]
4. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
[No Abstract] [Full Text] [Related]
5. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
Speth RC
Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
[No Abstract] [Full Text] [Related]
6. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
Sever P; Johnston SL
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926911. PubMed ID: 32403977
[No Abstract] [Full Text] [Related]
7. COVID-19, Renin-Angiotensin System, and Hematopoiesis.
Çiftçiler R; Haznedaroğlu İC
Turk J Haematol; 2020 Aug; 37(3):207-208. PubMed ID: 32394689
[No Abstract] [Full Text] [Related]
8. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
Patel AB; Verma A
Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
[No Abstract] [Full Text] [Related]
10. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
Silhol F; Sarlon G; Deharo JC; Vaïsse B
Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915
[No Abstract] [Full Text] [Related]
11. Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.
Quinn KL; Fralick M; Zipursky JS; Stall NM
CMAJ; 2020 Jun; 192(22):E611. PubMed ID: 32575050
[No Abstract] [Full Text] [Related]
12. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury.
Kow CS; Hasan SS
J Am Soc Nephrol; 2020 Aug; 31(8):1917-1918. PubMed ID: 32639940
[No Abstract] [Full Text] [Related]
13. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
14. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
15. RAAS Inhibitors and Risk of Covid-19.
Sriram K; Loomba R; Insel PA
N Engl J Med; 2020 Nov; 383(20):1991-1992. PubMed ID: 33108103
[No Abstract] [Full Text] [Related]
16. RAAS Inhibitors and Risk of Covid-19.
Angeli F; Verdecchia P; Reboldi G
N Engl J Med; 2020 Nov; 383(20):1990-1991. PubMed ID: 33108102
[No Abstract] [Full Text] [Related]
17. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
Ruilope LM; Tamargo J; Ruiz-Hurtado G
Eur Heart J; 2020 Jun; 41(22):2067-2069. PubMed ID: 32498078
[No Abstract] [Full Text] [Related]
18. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.
Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M
Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189
[No Abstract] [Full Text] [Related]
19. Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
Mahajan K; Gaur N
Diabetes Metab Syndr; 2020; 14(5):723-724. PubMed ID: 32473902
[No Abstract] [Full Text] [Related]
20. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
Dudoignon E; Moreno N; Deniau B; Coutrot M; Longer R; Amiot Q; Mebazaa A; Pirracchio R; Depret F; Legrand M
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):453-455. PubMed ID: 32565254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
